Perseus Proteomics Inc. (TYO:4882)
Japan
· Delayed Price · Currency is JPY 407.00
+7.00 (1.75%)
Jun 25, 2025, 3:30 PM JST
Perseus Proteomics Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
| Revenue | 120.38 | 100 | 94 | 71 | 67 | Upgrade
|
| Revenue Growth (YoY) | 20.38% | 6.38% | 32.39% | 5.97% | -21.18% | Upgrade
|
| Cost of Revenue | 16.32 | 13 | 7 | 5 | 4 | Upgrade
|
| Gross Profit | 104.05 | 87 | 87 | 66 | 63 | Upgrade
|
| Selling, General & Admin | 930.48 | 366 | 290 | 231 | 162 | Upgrade
|
| Research & Development | - | 616 | 494 | 308 | 313 | Upgrade
|
| Other Operating Expenses | 3.27 | - | - | - | - | Upgrade
|
| Operating Expenses | 933.75 | 982 | 784 | 539 | 475 | Upgrade
|
| Operating Income | -829.7 | -895 | -697 | -473 | -412 | Upgrade
|
| Interest & Investment Income | 1.95 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -2.89 | 16 | 7 | 9 | 1 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.81 | -1 | - | -19 | - | Upgrade
|
| EBT Excluding Unusual Items | -829.83 | -880 | -690 | -483 | -411 | Upgrade
|
| Asset Writedown | -72.51 | -153 | -95 | -117 | -1 | Upgrade
|
| Other Unusual Items | - | -70 | - | 2 | - | Upgrade
|
| Pretax Income | -902.34 | -1,103 | -785 | -598 | -412 | Upgrade
|
| Income Tax Expense | 2.46 | 1 | 1 | 1 | 1 | Upgrade
|
| Net Income | -904.8 | -1,104 | -786 | -599 | -413 | Upgrade
|
| Net Income to Common | -904.8 | -1,104 | -786 | -599 | -413 | Upgrade
|
| Shares Outstanding (Basic) | 14 | 12 | 12 | 11 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 12 | 12 | 11 | 7 | Upgrade
|
| Shares Change (YoY) | 21.05% | 0.24% | 6.94% | 57.10% | 13.88% | Upgrade
|
| EPS (Basic) | -63.41 | -93.65 | -66.84 | -54.47 | -59.00 | Upgrade
|
| EPS (Diluted) | -63.41 | -93.65 | -66.84 | -54.47 | -59.00 | Upgrade
|
| Free Cash Flow | -794.64 | -976 | -728 | -509 | -424 | Upgrade
|
| Free Cash Flow Per Share | -55.69 | -82.80 | -61.91 | -46.29 | -60.57 | Upgrade
|
| Gross Margin | 86.44% | 87.00% | 92.55% | 92.96% | 94.03% | Upgrade
|
| Operating Margin | -689.26% | -895.00% | -741.49% | -666.20% | -614.93% | Upgrade
|
| Profit Margin | -751.65% | -1104.00% | -836.17% | -843.66% | -616.42% | Upgrade
|
| Free Cash Flow Margin | -660.14% | -976.00% | -774.47% | -716.90% | -632.84% | Upgrade
|
| EBITDA | -826.86 | -892 | -692 | -471 | - | Upgrade
|
| D&A For EBITDA | 2.85 | 3 | 5 | 2 | - | Upgrade
|
| EBIT | -829.7 | -895 | -697 | -473 | -412 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.